Neogen Corporation Form DEF 14A: Definitive proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-21: Form DEF 14A; Period of report 2026-08-21; Description DEF 14A; Document neog-20260821.htm.
- 2025-09-12: Form DEF 14A; Period of report 2025-09-12; Description DEF 14A; Document neog-20250912.htm.
- 2024-09-13: Form DEF 14A; Period of report 2024-10-24; Description DEF 14A; Document neog-20240913.htm.
- 2023-09-18: Form DEF 14A; Period of report 2023-10-25; Description DEF 14A; Document neog-20230918.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-21 | DEF 14A | 2026-08-21 | DEF 14A | neog-20260821.htm |
| 2025-09-12 | DEF 14A | 2025-09-12 | DEF 14A | neog-20250912.htm |
| 2024-09-13 | DEF 14A | 2024-10-24 | DEF 14A | neog-20240913.htm |
| 2023-09-18 | DEF 14A | 2023-10-25 | DEF 14A | neog-20230918.htm |
| 2022-08-30 | DEF 14A | 2022-10-06 | DEF 14A | d399565ddef14a.htm |
| 2021-08-31 | DEF 14A | 2021-10-07 | DEF 14A | d147289ddef14a.htm |
| 2020-08-31 | DEF 14A | 2020-10-08 | DEF 14A | d15066ddef14a.htm |
| 2019-08-27 | DEF 14A | 2019-10-03 | DEF 14A | d780962ddef14a.htm |
| 2018-08-28 | DEF 14A | 2018-10-04 | DEF 14A | d607019ddef14a.htm |
| 2017-08-30 | DEF 14A | 2017-10-05 | DEF 14A | d433515ddef14a.htm |
| 2016-08-31 | DEF 14A | 2016-10-06 | DEF 14A | d245015ddef14a.htm |
| 2015-08-28 | DEF 14A | 2015-10-01 | DEF 14A | d93716ddef14a.htm |
| 2014-08-29 | DEF 14A | 2014-10-02 | DEF 14A | d773456ddef14a.htm |
| 2013-08-30 | DEF 14A | 2013-10-03 | DEFINITIVE PROXY STATEMENT | d588226ddef14a.htm |
| 2012-08-31 | DEF 14A | 2012-10-04 | DEFINITIVE PROXY STATEMENT | d399302ddef14a.htm |
| 2011-09-01 | DEF 14A | 2011-10-06 | DEFINITIVE PROXY STATEMENT | ddef14a.htm |
| 2010-09-01 | DEF 14A | 2010-10-07 | DEFINITIVE PROXY STATEMENT | ddef14a.htm |
| 2009-09-01 | DEF 14A | 2009-10-08 | DEFINITIVE PROXY STATEMENT | ddef14a.htm |
| 2008-09-02 | DEF 14A | 2008-10-09 | DEFINITIVE PROXY STATEMENT | ddef14a.htm |
| 2007-09-04 | DEF 14A | 2007-10-11 | DEFINITIVE NOTICE AND PROXY | ddef14a.htm |
| 2006-09-11 | DEF 14A | 2006-10-12 | DEFINITIVE PROXY STATEMENT | ddef14a.htm |
| 2005-09-09 | DEF 14A | 2005-10-13 | DEFINITIVE PROXY STATEMENT | ddef14a.htm |
| 2004-09-07 | DEF 14A | 2004-10-14 | DEFINITIVE NOTICE AND PROXY STATEMENT | ddef14a.htm |
| 2003-09-02 | DEF 14A | 2003-10-02 | DEFINITIVE PROXY STATEMENT | ddef14a.htm |
| 2002-08-29 | DEF 14A | 2002-10-09 | DEFINITIVE PROXY STATEMENT | ddef14a.txt |
| 2001-09-07 | DEF 14A | 2001-10-05 | NOTICE AND PROXY STATEMENT | ddef14a.txt |
| 2000-08-28 | DEF 14A | 2000-10-05 | NOTICE AND PROXY | 0001.txt |
| 1999-08-27 | DEF 14A | 1999-10-07 | Definitive proxy statement | |
| 1998-08-25 | DEF 14A | 1998-10-08 | Definitive proxy statement | |
| 1997-08-28 | DEF 14A | 1997-10-09 | DEFINITIVE 14A | |
| 1996-08-27 | DEF 14A | 1996-10-10 | PROXY STATEMENT/CARD | |
| 1995-08-31 | DEF 14A | 1995-10-05 | DEFINITIVE PROXY STATEMENT |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |